Shionogi delays filing for COVID-19 drug approval

The delay was due to the lack of enough participants for a clinical trial of the oral drug currently being developed by the pharmaceutical firm.

参照元:Japan Times latest articles

コメントする

メールアドレスが公開されることはありません。